• 1
    Price AH, Clissold SP. Salbutamol in the 1980s. A reappraisal of its clinical efficacy. Drugs 1989; 38: 77122.
  • 2
    Brittain RT, Farmer JB, Marshall RJ. Some observations on the β-adrenoceptor agonist properties of the isomers of salbutamol. Br J Pharmacol 1973; 48: 144147.
  • 3
    Evans ME, Walker SR, Brittain RT, Paterson JW. The metabolism of salbutamol in man. Xenobiotica 1973; 3: 113120.
  • 4
    Morgan DJ, Paull JD, Richmond BH, Wilson-Evered E, Ziccone SP. Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. Br J Clin Pharmacol 1986; 22: 587593.
  • 5
    Goldstein DA, Tan YK, Soldin SJ. Pharmacokinetic and absolute bioavailability of salbutamol in healthy adult volunteers. Eur J Clin Pharmacol 1987; 32: 631634.
  • 6
    Baba S, Goromaru T, Kawaguchi I, Kishi K. Urinary excretion of salbutamol enantiomers in man by stable isotope tracer technique. Iyakuhin Kenkyu 1981; 12: 8490.
  • 7
    Tan YK, Soldin SJ. Analysis of salbutamol enantiomers in human urine by chiral high–performance liquid chromatography and preliminary studies related to the stereoselective disposition kinetics in man. J Chromatogr 1987; 442: 187195.
  • 8
    Pesola GR, Walle T. Enantiomeric interaction in the sulfate conjugation of the β2,-agonist drug albuterol by the humanliver. Res Commun Chem Pathol Pharmacol 1992; 75: 125128.
  • 9
    Walle UK, Pesola GR, Walle T. Stereoselective sulphate conjugation of salbutamol in humans: comparison of hepatic, intestinal and platelet activity. Br J Clin Pharmacol 1993; 35: 4138.
  • 10
    Walle T, Walle UK, Thornburg KR, Schey KL. Stereoselective sulfation of albuterol in humans. Biosynthesis of the sulfate conjugate by HEP G2 cells. Drug Metab Dispos Biol Fate Chem 1993; 21: 7680.
  • 11
    Borgström L, Nyberg L, Jönsson S, Lindberg C, Paulson J. Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate. Br J Clin Pharmacol 1989; 27: 4956.
  • 12
    Borgström L, Kennedy BM, Nilsson B, Angelin B. Relative absorption of the two enantiomers of terbutaline after duodenal administration. Eur J Clin Pharmacol 1990; 38: 621623.
  • 13
    Boulton DW, Fawcett JP. Determination of salbutamol enantiomers in human plasma and urine by chiral high pressure liquid chromatography. J Chromatogr B (in press).
  • 14
    Bland RE, Tanner RJN, Chern WH, Lang JR, Powell JR. Determination of albuterol concentrations in human plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detection. J Pharm Biomed Anal 1990 8: 591596.
  • 15
    Martin LE, Hobson JC, Page JA, Harrison C. Metabolic studies of salbutamoL3H: A new bronchodilator, in rat, rabbit, dog and man. Eur J Pharmacol 1971; 14: 183199.
  • 16
    Walker SR, Evans ME, Richards AJ, Paterson JW. The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther 1972; 13: 861867.
  • 17
    Powell ML, Weisberger M, Gural R, et al. Comparative bioavailability and pharmacokinetics of three formulations of albuterol. J Pharm Sci 1985; 74: 217219.
  • 18
    Vaisman N, Koren G, Goldstein D, et al. Pharmacokinetics of inhaled salbutamol in patients with cystic fibrosis versus healthy young adults. J Pediatrics 1987; 111:14917.
  • 19
    Powell ML, Chung M, Weisberger M, et al. Multiple-dose albuterol kinetics. J Clin Pharmacol 1986; 26: 643646.
  • 20
    Hussey EK, Donn KH, Powell JR, Lahey AP, Pakes GE. Albuterol extended-release products: Effect of food on the pharmacokinetics of single oral doses of Volmax® and Proventil® Repetabs® in healthy male volunteers. J Clin Pharmacol 1991; 31: 561564.
  • 21
    Lipworth BJ, Clark RA, Dhillon DP, et al. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol 1989; 37: 567571.
  • 22
    Bai SA, Walle UK, Wilson MJ, Walle T. Stereoselective binding of the (-) enantiomer of propranolol to plasma and extravascular binding sites in the dog. Drug Metab Dispos 1983; 11: 394399.
  • 23
    Walle T, Webb JG, Bagwell EE, Walle UK, Daniell HB, Gaffney TE. Stereoselective delivery and actions of beta receptor antagonists. Biochem Pharmacol 1988; 37: 115124.
  • 24
    Kurosawa N, Owada E, Kato A, Bando K, Ito K, Kurosawa S. Serum concentration and cardiovascular effects of salbutamol after oral and rectal administration in healthy volunteers. J Clin Pharmacol Ther 1993; 18: 103108.
  • 25
    Morley J, Chapman ID, Foster A, Hoshiko K, Mazzoni L. Effects of (+) and racemic salbutamol on airway responses in the guinea-pig. Br J Pharmacol 1991; 104: 295P.